Zobrazeno 1 - 10
of 170
pro vyhledávání: '"Yang Luo"'
Publikováno v:
Stem Cells International, Vol 2023 (2023)
Currently, the first-line treatment for autoimmune hepatitis (AIH) is still the combination of glucocorticoids or immunosuppressants. However, hormone and immunosuppressive therapy can cause serious side effects, such as Cushing syndrome and bone mar
Externí odkaz:
https://doaj.org/article/28e5087d012b4ccb9b574488f282b0d7
Autor:
Fei Ma, Yanxia Sun, Qing Li, Peng Yuan, Shanshan Chen, Jiayu Wang, Yang Luo, Ying Fan, Pei Yu, Binghe Xu, Yiqun Han, Ruigang Cai, Qiao Li, Pin Zhang
Publikováno v:
Clinical Breast Cancer. 21:e497-e505
Different clinicopathologic characteristics could contribute to inconsistent prognoses of small breast neoplasms (T1a/T1b). This study was done to conduct a retrospective analysis and establish a clinical prediction model to predict individual surviv
Publikováno v:
Recent Patents on Anti-Cancer Drug Discovery. 16:407-416
Background: N6-Methyladenosine (m6A) RNA methylation is the most universal mRNA modification in eukaryotic cells. M6A mRNA modification affects almost every phases of RNA processing, including splicing, decay, export, translation and expression. Seve
Autor:
Gianluca Franceschini, Mingzhou Li, Mohammed A. Osman, Xue Wang, Gustavo N Marta, Shanbo Cao, Yang Luo, Yoichi Naito, Giuseppe Lippi, Nanlin Hu, Pin Zhang, Armando Orlandi, Jian Yue, Binghe Xu, Fei Ma, Peng Yuan, Wenmiao Wang, Jiayu Wang, Anjie Zhu, Qing Li
Publikováno v:
Cancer Biology & Medicine, Vol 18, Iss 3, Pp 875-887 (2021)
Cancer Biology & Medicine
Cancer Biology & Medicine
Objective: Apatinib is an oral TKI targeting VEGFR-2. Single-agent apatinib treatment has been shown to produce an objective response in patients with pretreated mBC. Oral vinorelbine also holds promise as a treatment of choice in patients with mBC.
Autor:
Fei Ma, Binghe Xu, Shanshan Chen, Yang Luo, Peng Yuan, Ying Fan, Qing Li, Xuelian Chen, Qiao Li, Jiayu Wang, Ruigang Cai, Pin Zhang
Publikováno v:
Clinical Breast Cancer. 21:191-198
It is difficult to define patients with primary trastuzumab resistance (PTR) after (neo)adjuvant trastuzumab with minimal data and understanding of the actual prevalence, prognosis, and potential treatment strategies in the real-world setting.The med
Autor:
Bin Su, Guiju Gao, Min Wang, Yanqiu Lu, Linghua Li, Chen Chen, Yuanyuan Chen, Chuan Song, Fengting Yu, Ying Li, Yixin Liu, Yang Luo, Haolan He, Cong Cheng, Lixia Xu, Tong Zhang, Lijun Sun, An Liu, Wei Xia, Yuanyuan Qin, Qingxia Zhao, Hongxia Wei, Weiping Cai, Yaokai Chen, Fujie Zhang, Hao Wu
Publikováno v:
The Lancet Regional Health - Western Pacific. :100769
Autor:
Qing Li, Pin Zhang, Qiao Li, Fei Ma, Binghe Xu, Yang Luo, Jiayu Wang, Zijing Wang, Jiaxuan Liu, Ying Fan, Peng Yuan
Publikováno v:
Breast Cancer Research and Treatment
Purpose We conducted a single-arm prospective phase II trial to evaluate the efficacy and safety of oral metronomic vinorelbine combined with trastuzumab (mNH) in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast can
Autor:
Ying Fang, Qing Li, Binghe Xu, Jiani Wang, Fei Ma, Pin Zhang, Qiao Li, Ruigang Cai, Jiayu Wang, Peng Yuan, Yang Luo
Publikováno v:
Cancer Research. 81:PS6-28
Background: Metaplastic breast cancer (MBC) is a rare subtype with distinct clinicopathological features, but few studies have concerned the prognosis of this rare and morphologically diverse malignancy. A prognostic index estimating the clinical out
Autor:
Shanshan Chen, Yimeng Chen, Pin Zhang, Yiqun Li, Binghe Xu, Qiao Li, Shaoyan Lin, Qing Li, Ying Fan, Yang Luo, Jiayu Wang, Zijing Wang, Ruigang Cai, Xiuwen Guan, Fei Ma, Hongnan Mo, Ye Zhang, Dainan Zhang, Peng Yuan
Publikováno v:
Cancer Research. 81:PS7-87
Background: To characterize the incidence, treatment and survival of patients with brain metastases at initial diagnosis of metastatic breast cancer (MBC) in China. Methods: The China National Cancer Center database was used to identify 2087 MBC pati
Publikováno v:
J Assist Reprod Genet
RESEARCH QUESTION: Granulosa cells (GCs) surrounding oocytes are crucial for follicular growth, oocyte development, ovulation, and luteinization under the dynamic co-stimulation of follicle stimulating hormone (FSH) and luteinizing hormone (LH). This